Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04117217 · ClinicalTrials.gov registry record
Risk Factors for Thrombosis in Children With Central Venous Lines
A clinical trial, sponsored by University of Arizona.
- Completed
- Registry status
- 200
- Enrollment target
NCT04117217: Completed study, sponsored by University of Arizona.
NCT04117217 is a clinical trial that has completed, run by University of Arizona. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04117217 has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This project addresses the role of lab markers around the time of central line placement in predicting risk of thrombosis in pediatric patients with central venous lines being placed. The project proposes an innovative way to predict higher risk of thrombosis in the pediatric population to give clinicians a valid tool to guide clinical practice for these patients.
Primary Outcome
Patients will be enrolled during the time of central line placements and labs would be drawn during line placement. Patients will be followed prospectively for a catheter related t thrombosis event or not. Lab markers and clinical states of patients who develop or do not develop a thrombosis will be analyzed
Interventions
- DIAGNOSTIC_TEST Labs drawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2021-12-31 |
What the finished NCT04117217 record still lists
NCT04117217 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Labs drawn is the first listed.
NCT04117217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04117217 about?
NCT04117217 is a clinical study titled "Risk Factors for Thrombosis in Children With Central Venous Lines". This project addresses the role of lab markers around the time of central line placement in predicting risk of thrombosis in pediatric patients with central venous lines being placed. The project proposes an innovative way to predict higher risk of thrombosis in the pediatric population to give clin...
What is the current status of trial NCT04117217?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-03-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04117217?
The interventions under investigation include: Labs drawn (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04117217?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI